Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Coutré

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Annual Review of Medicine|January 1, 1995
Novel antithrombotic therapeutics targeted against platelet glycoprotein IIb/IIIaS Coutré, L Leung
Circulation|September 1, 1994
Synthetic peptide thrombin inhibitorA DeAnda, S Coutré, D C Miller
The Journal of Experimental Medicine|December 1, 1986
Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusionJ Lifson, S Coutré, E Huang, et al.
Journal of Medicinal Chemistry|June 19, 1998
N2- and C8-substituted oligodeoxynucleotides with enhanced thrombin inhibitory activity in vitro and in vivoG X He, S H Krawczyk, S Swaminathan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failedM J Keating, B Cazin, S Coutré, et al.
Journal of Medicinal Chemistry|October 23, 1998
In vitro and in vivo activities of oligodeoxynucleotide-based thrombin inhibitors containing neutral formacetal linkagesG X He, J P Williams, M J Postich, et al.
Leukemia|October 22, 2005
The evolving role of alemtuzumab in management of patients with CLLS Faderl, S Coutré, J C Byrd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemiaS L Soignet, S R Frankel, D Douer, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Annual Review of Medicine|January 1, 1995
Novel antithrombotic therapeutics targeted against platelet glycoprotein IIb/IIIaS Coutré, L Leung
Circulation|September 1, 1994
Synthetic peptide thrombin inhibitorA DeAnda, S Coutré, D C Miller
The Journal of Experimental Medicine|December 1, 1986
Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusionJ Lifson, S Coutré, E Huang, et al.
Journal of Medicinal Chemistry|June 19, 1998
N2- and C8-substituted oligodeoxynucleotides with enhanced thrombin inhibitory activity in vitro and in vivoG X He, S H Krawczyk, S Swaminathan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failedM J Keating, B Cazin, S Coutré, et al.
Journal of Medicinal Chemistry|October 23, 1998
In vitro and in vivo activities of oligodeoxynucleotide-based thrombin inhibitors containing neutral formacetal linkagesG X He, J P Williams, M J Postich, et al.
Leukemia|October 22, 2005
The evolving role of alemtuzumab in management of patients with CLLS Faderl, S Coutré, J C Byrd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemiaS L Soignet, S R Frankel, D Douer, et al.
Pageof 1